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Luxembourg, Luxembourg, LuxembourgABSTRACT In this study we have applied a model to explain the reported subdiffusion of particles in mucus, based on the
measured mean squared displacements (MSD). The model considers Brownian diffusion of particles in a confined geometry,
made from permeable membranes. The applied model predicts a normal diffusive behavior at very short and long time lags,
as observed in several experiments. In between these timescales, we find that the ‘‘subdiffusive’’ regime is only a transient effect,
MSDfta;a< 1. The only parameters in the model are the diffusion-coefficients at the limits of very short and long times, and the
distance between the permeable membranes L. Our numerical results are in agreement with published experimental data for
realistic assumptions of these parameters. Finally, we show that only particles with a diameter less than 40 nm are able to
pass through a mucus layer by passive Brownian motion.INTRODUCTIONBiological barriers are crucial in protecting our body from
environmental influences. Well-known outer barriers are
intestinal, pulmonary, nasal, buccal, cervico-vaginal, and
dermal barriers. Except for the dermal barrier, all these
are covered by a mucus layer, providing an additional bar-
rier to the epithelial cell layer.
For particle-based drug delivery systems, this mucus
layer generates an extra challenge. Mucus is a complex,
heterogeneous polymer-scaffold with viscoelastic proper-
ties. It consists of mainly mucins, which are large semi-
flexible glycoproteins, and of an interstitial fluid with
low viscosity (see Fig. 1). Either these glycoproteins
are dissolved or membrane-bound. Thus, solid drug deliv-
ery systems and penetration of particulate matter, such as
viruses, bacteria, and dust are affected. The main compo-
nent of mucus is the interstitial fluid, which essentially
consists of water, depending on its site of secretion.
Moreover, thickness, composition, and rheological prop-
erties of the mucus layer depend on physiological condi-
tions, regions, species, and functions of the respective
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 2017To reduce systemic side effects by the therapy of bron-
chial diseases, e.g., cystic fibrosis (CF), local applications
of drug delivery systems are desirable. However, in the
bronchial regions of the lung, pulmonary mucus is present,
where its function is the clearance of particulate xenobi-
otics, mucosal insults, water balance, ion transport, and
ion regulation. To overcome this biological barrier caused
by some novel inhalation pharmaceuticals, functionalized
and nontoxic nanocarriers can be used. Inspired from vi-
ruses, nanosized particles with neutrally charged coatings
such as polyethylene glycol (PEG) can efficiently penetrate
the mucus layer in contrast to charged particles (1–12).
The average thickness of the mucus layer in the bronchial
regions is about 55 mm (5). Mucus is continuously trans-
ported out of the lung through the aligned movement of
the cilia, and this process is called the mucociliary clear-
ance. Besides the mucociliary clearance, which requires
~10–20 min in the main bronchi to renew the mucus layer,
mucus can also be cleared by enzymatic or bacterial degra-
dation (2,5,9). Naturally, the size of particles and mucus
pores, the viscosity of the interstitial fluid, and the entire
mucus-structure are equally important factors for particle
diffusion. The macrorheological viscosity of sputum from
CF patients is ~70 Pas at a shear rate of 0.1 s1 (13), and
the amplitude of the complex viscosity at u ¼ 1 rads1 of
pulmonary mucus from humans without lung disease is
FIGURE 1 Scanning electron microscopic image of horse pulmonary
mucus (6).
Transient Subdiffusive Behavior~10 Pas (11). In contrast, the microrheological viscosity of
the interstitial fluid is similar to that of water, typically in
order of few mPas (13).
For drug delivery and the understanding of how viruses
can affect the body, it is important to study drug and
particle transport through mucus (see (2,3) and the refer-
ences therein). Various models assumes Fick’s second
law and predict therefore a time-independent diffusion
coefficient D, however as the function of specific mucus,
particle, or drug properties. In particular, for particles,
microrheological experiments can be performed to obtain
local information about the mucus. Some experiments
showed a nonlinear mean squared displacement (MSD(t))
of these particles as function of the time lag t (11,13).
Erickson et al. suggested a mathematically motivated
model of a timescaled and a fractional subdiffusion
approach to describe a ‘‘subdiffusive’’ behavior in
MSD(t) data (14). The authors justify their model with
the experimental data for HIV-virions in human cervical
mucus (15). The scaffold structure of mucus in Fig. 1 indi-
cates a ‘‘cage-effect.’’ Some studies call it a transient cage-
effect, which is assumed as the reason of the restricted
diffusion for longer timescales and length scales, respec-
tively (16–19). Existing theoretical approaches deal with
three-dimensional (3D) (20–22), two-dimensional (2D)
(23,24), and one-dimensional (1D) systems (25,26) to
describe the restricted diffusion of particles. In particular,
the studies of Dudko et al. (22,25) introduced a physically
motivated model of normal Brownian diffusion of mole-
cules or particles in a scaffold structure to mimic a hetero-
geneous material made from reflecting walls and apertures
(22,24,25). However, these studies do not refer to mucosal
model systems. Based on normal diffusion, their model
also predicts a nonlinear subdiffusive MSD(t), but as a
transient effect between intervals of normal diffusive
behavior. The publication of Hansing et al. (27) used acomprehensive theoretical model to include the interpar-
ticle and particle-boundary interaction.
In this study, we adjust the model from Dudko et al.
(22,25) to data of particle diffusion experiments in mucus
(11,13). We adapt model parameters for comparison to
obtain physical interpretable quantities. In addition, to sup-
port the model, we introduce another very efficient way of
simulating particle trajectories through permeable mem-
branes. This approach is based on the simulation of particle
trajectories in presence of Robin boundaries (28).
In the following sections, we adapt the model from
Dudko et al. (22,25) and discuss the assumptions of
condensing the scaffold structure to simulate diffusion in
an environment with periodic permeable membranes. Addi-
tionally, we present a heuristic approximation (22), which
yields a simple analytic expression for the MSD(t) as the
function of only a few physical interpretable parameters,
related to the physical properties of the mucus and the
immersed particles. To justify the approximated formula,
we introduce a simulation of Brownian particles in presence
of permeable membranes as Robin boundaries. This
approach aims to provide a better interpretation of
the experimentally achieved data and may contribute
new insights for improving the design of particle-based
drug delivery systems. Therefore, finally we estimate the
maximum particle size to penetrate the mucus layer by
passive Brownian motion. We discuss further thoughtful
experimental improvements and data analysis approaches
in the conclusion.MATERIALS AND METHODS
In this section, we adapt the model from (22). to describe the diffusion of
particles in the assumed confined geometry. We present the basic idea,
the mathematical equations, and its limitations. Finally, we discuss the
particular Brownian diffusion model, using exemplary numerical simula-
tions, based on permeable membranes with a certain permeability.Idea
Fig. 1 suggests a model of mucus, which is based on a porous structure of
Newtonian fluid-filled random-sized cells (cavities) with apertures of
various sizes. To simplify the system to a simple cubic lattice of cavities
with connecting apertures, the mucus is characterized by a mean cavity
extension L and a mean aperture diameter (see Fig. 2 A ). Therefore, L refers
to the edge size of one cell (cavity) in the cubic lattice of cavities, i.e., the
distance between the cavity interfaces. That system is still anisotropic in the
sense of the 3D diffusion equation, because of the fact that the boundary
conditions are not separable. Hence, the details of the scaffold structure
are condensed by the ‘‘boundary homogenization’’ method assuming
permeable membranes in all spatial directions, and quantified by a certain
permeability of the membranes for the particles (see Fig. 2, B and C). The
mathematical properties of the model are discussed in (20–24,26,29,30).
This homogenization yields to an isotropic system for diffusing particles.
The 3D system is reduced to a 1D system, as it is discussed in detail in
(22,25). Especially an exact analytic expression for the Laplace transform
of MSD(t) is given, but the inverse Laplace transform must be performed
numerically.Biophysical Journal 112, 172–179, January 10, 2017 173
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FIGURE 2 (A) A 3D representation of a unit cell
as a single cubic cavity with edge size L with re-
flecting walls and apertures, the precursor for the
mucus model. The red sphere depicts a tracer
particle. (B) Representation of the model using
permeable membranes as interfaces is shown. (C)
Exemplary trajectories of particles as 2D projec-
tion are illustrated to visualize the Brownian diffu-
sion inside the cavity and the restricted passing
through the membranes, shown as black dashed
lines. To represent the trajectories, we use the
initial position as the center of the cavity, indicated
by the yellow cross; otherwise, in the simulations,
the initial positions are random. To see this figure
in color, go online.
Ernst et al.Model
Inside the cavities, the particles diffuse normally and unrestrictedly with a
diffusion coefficient given by the following Stokes-Einstein relation
(3,31,32):
D0ðh;RÞ ¼ kBT
6phR
; (1)
with the absolute temperature T, the viscosity h of the interstitial fluid, and
the hydrodynamic radius R of the particle. The model is isotropic because of
the homogeneous membranes. Therefore, we only consider the 1D unbiased
diffusion of particles exemplary in the x-direction from this point onward. A
very common statistical characterization of the stochastic motion of particle
trajectories is the MSD(t) of particle positions with respect to its initial
position, given as follows:
MSD1DðtÞ ¼
ðxðtÞ  xð0ÞÞ2; (2)
where the h,i denotes the ensemble average and t is the time interval. In
case of a random initial position, the particular choice of the initial time
is not important. The system becomes ergodic. To improve the statistics174 Biophysical Journal 112, 172–179, January 10, 2017from experimentally obtained trajectories, and sometimes, in numerical
simulations, frequently an additional time-average is performed (19).
The suitable combination of two analytical limits yields in the mentioned
heuristic analytic equation for the MSD as in (22). At small length scales
and times ðt/0Þ, the diffusion of a particle is not affected by the walls,
and the motion is unbounded and characterized by a linearMSD(t), accord-
ing to the following Einstein-Smoluchowski equation (31,33,34):
MSD1DðtÞ ¼ 2D0t at t/0: (3)
As the second analytical limit, we consider the MSD(t) of diffusing but
trapped particles in an interval with completely reflecting walls. As com-
mon in experiments, the average of a uniform distribution of the initial po-
sition in the interval [0;L] is taken into account. The analyticalMSDL(t ) is
given as follows (see appendices in (22,35)):
MSDLðtÞ ¼ L
2
6
 16L
2
p4
XN
m¼ 1
ðoddÞ
1
m4
exp

 m
2p2D0
L2
t

: (4)
Note that the same equation is reported in (22) as Eq. 2.8; however, there is
an error in the coefficient of the sum. The series in Eq. 4 converges very
Transient Subdiffusive Behaviorquickly, and the calculation can be truncated after a few elements (m< 15),
but it still maintains a reasonable accuracy. The suitable combination of
both limits yields in the mentioned heuristic analytic equation for the
MSD (22). The analytically small time interval limit ðt/0Þ of Eq. 4 obeys
Eq. 3. In the limit of a long time interval ðt/NÞ, theMSD is saturated to a
constant value of L2=6 (see Fig. 3 A with pM ¼ 0).
In the case of permeable membranes, the particles can diffuse without
constricting even for periodic repetitions. Based on the central limit theo-
rem, the diffusion at longer time periods is considered as normal with a
smaller diffusion coefficient Deff <D0.
To quantify the permeable membranes, we introduce the permeability pM
as a parameter in our numerical simulations. Note that pM is directly related
to Deff . An approximate approach to calculate Deff as function of the aper-
ture size and the mean cavity size L can be found in (23,24). The limiting
cases of total reflection and total transmission are represented by
pM ¼ 0ðDeff ¼ 0Þ and pM ¼NðDeff ¼ D0Þ, respectively (see Fig. 3 A).
pM is neither the permeability in units of m
2 defined using Darcy’s law
nor the probability of transmission/reflection if a particle hits the mem-
brane. However, the probability of reflection is introduced as rðpMÞ in
our numerical simulations (see below).
Our numerical simulation in the next section proves the following heuris-
tic approach: a good analytic approximation to calculate the MSD(t) inA
B
FIGURE 3 (A) Calculated MSD(t) of particles with a diameter of
200 nm in mucus using a membrane distance of L ¼ 0.35 mm and D0 ¼
0.65 mm2s1 for various permeability of the membranes pM and the
belonging Deff in the figure legend. Data from numerical simulations are
shown as symbols (Dt ¼ 1 ms) and are from an analytic approximation us-
ing Eq. 5 as lines. (B) The calculated anomaly exponent a to MSDðtÞfta
using Eq. 6 with the same legend as in (A) is shown. To see this figure in
color, go online.case of caged diffusion in presence of periodic permeable membranes is
the appropriate superposition of the solutions for free and trapped diffusion,
in Eqs. 3 and 4, respectively. The diffusion coefficients D0 and Deff as well
as the cavity size L are the only involved parameters:
MSDðtÞ ¼

1 Deff
D0

MSDLðtÞ þ 2Deff t: (5)
This combination fulfills the short and long time limits as discussed above.
It shows that the relative difference to the simulated results in the transient
region is mostly less than 7% and never more than 21%. Our numerical
simulation also confirms the following intuitive relation from the boundary
homogenization (24,29): the smaller the permeability pM of the mem-
branes, the lower the Deff will be, and vice versa. Naturally, the particle
radius determines the free diffusion coefficient D0ðh;RÞ by Eq. 1 and the
permeability through the membrane, i.e., the effective diffusion coefficient
DeffðpMðRÞ;L;D0Þ. Bigger particles cannot pass the apertures between the
cavities easily, thereby resulting in a reduced permeability, i.e., Deff be-
comes smaller. Hence, the only essential parameters for MSD(t) in Eq. 5
and in the simulations are D0 from the unrestricted diffusion at short times,
Deff from the restricted diffusion at long times, and L as the cavity size (see
Fig. 3 A). A direct consequence of the model is that theMSDfta, a< 1 ap-
pears only as a transient phenomenon, which should not be misinterpreted
as subdiffusion or abnormal diffusion (see Fig. 3 A and (26)).
It is common to plot the MSD(t) in a double-logarithmic scale to visu-
alize deviations from the normal diffusive behavior. Berezhkovskii et al.
(26) provided a good method to discriminate between anomalous diffusion
(subdiffusion) and transient subdiffusive behavior by calculating anomaly
exponents a in three different ways. In case of anomalous diffusion, a is
constant and independent of the method of determination. In our study,
we characterize the transient subdiffusive behavior by determining the
time-dependent anomaly exponent aðtÞ from the dimensionless logarith-
mic derivative of the MSD(t). This is given as follows (26,36,37):
aðtÞ ¼ d logðMSDðtÞÞ
d logðtÞ ¼
t
MSDðtÞ
dMSDðtÞ
dt
; (6)
and is shown in Fig. 3 B. Note that another possible characterization of the
nonlinear MSD(t) is given by a time-dependent diffusion coefficient
MSDðtÞ ¼ 2DðtÞt. Both characterizations are localized to a specific time
lag t and do not represent the overall nature of the system.
In all experiments, the accessible time range is limited by both the frame
rate of the camera and the maximal recorded time interval that the diffusing
particle is within the depth of field of the microscope for detection, e.g., t is
between 0.05 and 5 s (11,13). In Fig. 3, we used various Deff and a reason-
able interstitial fluid viscosity of h ¼ 3.5 mPas, which is similar to that of
water. Hence, the predicted time range of transition (subdiffusion) appears
within the typically experimental conditions.Limitations
The presented model focuses on a qualitative description, using only a few
parameters as possible. Therefore, we can neither cover the broad range of
existing mucus variations nor the various types of particle coatings. Using
only three physical interpretable parameters, we can reproduce themeasured
subdiffusive behavior. However, the subdiffusion reflected by a MSDfta,
a< 1, is identified as a transient behavior. It naturally appears due to the
continuous transition from normal, unrestricted diffusion MSDft at short
times to a normal, restricted diffusion at long timescales, longer distances
respectively, caused by the repeated confinement of the particles. The two
limiting normal diffusion regimes are quantized by the diffusion coefficients,
D0 and Deff , respectively. The third necessary parameter in the model is the
mean cavity size L. The transition regime should not be identified as anom-
alous diffusion in the sense of space-timescale invariant, continuous-timeBiophysical Journal 112, 172–179, January 10, 2017 175
Ernst et al.randomwalks, or as a fractionalBrownianmotion (26).Only one length scale
is added to the system, the mean cavity size L.FIGURE 4 Calculated ratio Deff/D0 with D0 ¼ 0.32 mm2s1 (R ¼
100 nm, h ¼ 7 mPas) as function of pM, respectively r, and various mem-
brane distances L. A Dt ¼ 1 ms was used in the numerical simulations. To
see this figure in color, go online.Numerical simulations
To substantiate the suggested approximation in Eq. 5, we performed numer-
ical simulations of the system. The Brownian motion of the nanosized par-
ticles in a liquid is described by an overdamped movement, as the inertia of
the particles does not play a role. We assume no external forces acting on
the particles. Under these assumptions, the unrestricted (free) motion of
the particles at all times is then described by the massless Smoluchowski
approximation of the following Langevin equation (33,38):
d
dt
xðtÞ ¼
ﬃﬃﬃﬃﬃﬃﬃﬃ
2D0
p
xðtÞ; (7)
with the particle position xðtÞ and the standard Gaussian noise xðtÞ. The
reduction to one dimension is explained above. A very efficient way to
simulate this stochastic equation at discrete times is given by the Euler-
Maruyama method (28,33,39,40) as follows:
xkþ1 ¼ xk þ Dxk with
Dxk ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2D0Dt
p
gk ; k ¼ 1;.;N  1; (8)
where N is the maximum number of time steps, Dt is the duration of the
discrete time step, and gk ˛ Nð0; 1Þ is a Gaussian distributed random num-
ber. We use a uniformly distributed initial position x0 ˛ ½0; L.
In presence of reflecting walls or permeable membranes, the particle mo-
tion must comply with the boundary conditions in each iteration. The treat-
ment of diffusion through permeable membranes is still a topic of current
research. We adapted the algorithm, referred as the Robin boundary condi-
tion, from (28,40) for partially reflecting and absorbingwalls. The permeable
membranes in our simulations are described by a random reflecting or pass-
ing of the wall, independent of the angle of impact. Hence, the iteration
scheme from Eq. 8 has to be modified.When the particle trace hits the mem-
brane, the probability of reflection must depend on the spatial resolution of
the simulation, i.e., the duration of the discrete time step. It becomes clear
that a shorter Dt leads to a more fractional trajectory, and there are more
hits to an (imaginary) wall in the same time span. To preserve the ratio of
transmissions per unit time, the probability of reflection at each hit must
be reduced. According to (28,40), we introduced the reflection probability r:
r ¼ 1 pM
ﬃﬃﬃﬃﬃﬃ
Dt
p
; (9)
with the permeability pM ˛ ½0;N of the membrane in units of s1=2. The
iteration scheme in Eq. 8 and the reflecting probability in Eq. 9 requires
a sufficiently small Dt to achieve accurate statistical quantities, at least
to preserve a r ˛ ½0; 1. This requirement results in a small time step Dt,
particularly in the limiting case of pM/N, and consequently Deff/D0.
The modified iteration scheme is given as follows:
xkþ1 ¼ xk þ

Dxk;r with r; if a membrane is crossed:
Dxk otherwise:
(10)
The displacement of the particle for being reflected by the periodic mem-
branes at x ¼ nL; n ˛ Z, is given as follows:
Dxk;r ¼
Dxk þ 2L 2 modðxk; LÞ; Dxk > 0
Dxk  2 modðxk; LÞ; Dxk < 0 ; (11)
using the modulus function mod. The Dxk > 0 represents a particle motion
from left to right and Dxk < 0 is the reverse. For more details, please see the176 Biophysical Journal 112, 172–179, January 10, 2017Supporting Material. Some exemplary trajectories in 2D are shown in Fig. 2
C. In this figure, the x and y components of each trajectory are two indepen-
dent 1D simulations. The particles are mostly caged in the current cavity,
but they can also pass through the borders/membranes with a certain prob-
ability 1 r.
The numerical simulation of long trajectories opens up the possibility to
determine the relation between the permeability pM used in the simulation
and the ratio of effective to free diffusivity Deff=D0. For various fixed lattice
constants L, see Fig. 4. As expected, the relation is strictly increasing, is
nonlinear, and saturates in unity for large permeability. A general analytic
derivation is still an open question (28,40). Note that the pM is neither in
direct relation to the permeability P nor the trapping rate k in (22,24,25);
the physical units are different. Our simulations are also different from
those former approaches (22,24,25), because of the explicit usage of perme-
able membranes instead of a 2D or 3D simulation of standard Brownian
motion in a cubic lattice with apertures of fixed size and reflecting walls.
Finally, the presented model predicts a transient subdiffusive behavior in
the experimental accessible time range between 0.05 and 5 s for realistic
parameter assumptions. For instance, for a particle diameter of 200 nm, a
cavity extension of L¼ 350 nm and using a permeability pM ¼ 0:05 results
in an effective mucus viscosity of 100 times more as it of the interstitial
fluid, see solid circles and black line in Fig. 3. A transient subdiffusive
time range also remains for other particle diameters because of the
following conclusion: smaller particles belong to a larger D0 (see Eq. 1)
and result in a larger expected Deff . Hence, the MSD(t) curve will shift up-
ward in the double logarithmic plot and for fixed L, and the time range with
subdiffusion will shift slightly to smaller values. The opposite is in the case
for bigger particles. Hence, a transient subdiffusive behavior is predicted for
any particle diameter if Deff  D0. However, if the particles become very
small, as they can pass the membranes or the scaffold structure very easily
(pM will increase), Deff will be in the order of magnitude of D0 and the sub-
harmonic region will disappear.RESULTS AND DISCUSSION
In this section, model predictions with measured MSD(t)
are compared by adapting the required parameters to obtain
a good visual agreement. The physical meaning of our re-
sults are discussed and compared with independent mea-
surements, if available. Results from other theoretical
studies (18,20–22,24,26,27,36) that used other assumptions
Transient Subdiffusive Behaviorand models predicted a similar shape of theMSD-curves and
anomaly exponent a were predicted (see Fig. 3) . We used
particle tracking data from uncoated, polystyrene (PS) par-
ticles in human sputum from CF patients (13) and from
coated PEGylated PS particles in pulmonary mucus from
humans without lung disease (11). A comprehensive model
with including interparticle and particle-boundary interac-
tions can be found in (27), where the simulated results
and the observed transient subdiffusive behavior are
compared with experimental studies.Uncoated particles in sputum from cystic fibrosis
patients
Usually, sputum has a lower viscosity than mucus. How-
ever, sputum from CF patients is characterized by a denser
mesh compared with pulmonary, healthy mucus (13). In
Fig. 5, a calculated MSD (using Eqs. 8–11) of 200-nm-
sized particles is shown as a dashed line and solid lines
refer to experimental MSD for different particles (see
(13)). Despite the fact that the MSD of different particles
differ strongly, the transient subdiffusive behavior with a
slope a < 1 is obvious. However, focusing on the slope
at short and long time lags t, the predicted transition to
normal diffusive behavior with a slope a ¼ 1 is evident,
both in the numerical and in the experimental data. At
short times t < 0.1 s, the predicted diffusion becomes
normal ða(1Þ and theMSD is proportional to the diffusion
coefficient D0 from the Stokes-Einstein relation in Eq. 1.
At long times t > 2 s, the predicted diffusion becomes
normal again but with an effective diffusion coefficient
Deff . The subdiffusive regime with az1=2 appears as a
transient effect and agrees with experimental observations.FIGURE 5 Comparison of experimental data and a calculatedMSD for a
particle with a diameter of 200 nm, indicated as a red dashed line. A mem-
brane distance of L ¼ 0.25 mm, with D0 ¼ 0.2 mm2s1, pM ¼ 0.05, and
therefore a ratio of Deff/D0 ¼ 0.02 was used. In the background, a figure
taken from (13) with experimental data for PS particles in human sputum
from CF patients (solid lines) is shown. The transient time regime of sub-
diffusion is marked. To see this figure in color, go online.The different offsets in the individual experimental MSDs,
calculated from different tracer trajectories, is certainly
attributable to the inhomogeneity of D0ðhð~rÞ;RÞ at a
particular tracer position ~r in the heterogeneous structure
of the sputum.
In Fig. 5, we used three parameters to adjust visually the
calculated MSD-curves to the experimental MSD-curves, a
D0 ¼ 0.2 mm2s1, a membrane distance of L ¼ 0.25 mm,
and a pM ¼ 0:05, resulting in a Deff ¼ 0.003 mm2s1. This
Deff is significantly less than the D0 in accordance with
the apparent subdiffusive behavior. The assumed frequent
number of permeable membranes per length scale (a small
L) is in good agreement with the dense structure of sputum
from CF patients. The assumed D0 belongs to a diffusivity
of 200 nm particles in a fluid with a viscosity only one order
of magnitude larger than that of water (see Eq. 1). In
contrast, the adjusted Deff , which is at least 60 times lower
than D0, corresponds to a free Brownian diffusion in a fluid
with a viscosity at least 800 times higher than that of water.
The influence of the permeable membranes becomes domi-
nant. However, this microrheological viscosity for diffusing
nanoparticles, is still much lower than the macrorheological
viscosity, where a reshaping and reorientation of the mem-
branes in the mucus-structure plays an important role.
More precisely, the assumed viscosity is 100 times lower
than the measured macrorheological viscosity (see (13)).
Note that according to the isotropy of the model, the 2D-
and 3D-MSD is given by the double and triple of the pre-
dicted 1D-MSD.
If the particles are coated by PEG are thus neutral (un-
charged), less adherent or repulsive interaction between par-
ticles and mucus is observed (9,10). Hence, the effective
diffusion coefficientDeff increases and becomes comparable
with D0, and consequently the transient subdiffusive regime
becomes less pronounced. This is the topic of the following
subsection.PEGylated PS-particles in pulmonary mucus from
humans without lung disease
In Fig. 6, three calculated MSDs are compared with the
experimental MSD of different sized particles in pulmo-
nary mucus from humans without lung disease (11).
Reasonable D0, Deff , and L are assumed to represent the
data. The different offset in the MSD for the 100 and
200 nm particles is simply because of the different D0
(see Eq. 1). This is because of the same assumed interstitial
fluid viscosity h. Due to the experimental fact of the less
dense scaffold of the pulmonary mucus in comparison
with sputum from CF patients described in the previous
section, in this section we assumed a larger cavity size
L ¼ 500 nm. However, the influence of the particular
choice of L is small because of the transient subdiffusive
behavior that is not as pronounced as in Fig. 5. Naturally,
the effective diffusion coefficient is similar to the D0 fromBiophysical Journal 112, 172–179, January 10, 2017 177
FIGURE 6 Comparison of calculated MSD for various parameters as the
red dash-dotted lines and measured data as background image from (11).
The experimental particle diameters in the figure legend are also used in
the calculations, as well as a membrane distance of L ¼ 0.5 mm for the
100 and 200 nm particles and L ¼ 0.15 mm for the 500 nm particles. The
parameters of (D0, Deff / D0, pM) are given as (top to bottom) (0.1
mm2s1, 0.9, 10), (0.05 mm2s1, 0.4, 0.5), and (0.002 mm2s1, 0.2, 0.01).
To see this figure in color, go online.
Ernst et al.the unrestricted motion. It seems there is only a minor in-
fluence on the diffusion of the small particles attributable
to the membranes.
The situation is different for the MSD curve of the
500 nm particles. The transient subharmonic behavior be-
comes visible at t R 1 s. For the simulations, we assumed
a larger viscosity h as for the smaller particles. Con-
sequently, D0 and Deff are smaller as expected from the
indicated particle size. This is in accordance with the
experimental observation: a larger apparent viscosity of
the mucus at small timescales due to a particle size compa-
rable with the cavity size because of increased steric
obstruction (1). The finite-sized particles are affected by
the scaffold structure at any timescale and the assumption
of point-like tracer particles in the model is not more
justified. In addition, we also assume a smaller distance
between the membranes L ¼ 150 nm, i.e., the mean cavity
size is as much smaller as the particle diameter.
This assumption is justified by the average pore size
(~50–200 nm) of pulmonary mucus given by scanning elec-
tronic microscopic images (see Fig. 2 in (11)). The
assumed small membrane distance for these particles is
also justified because of the heterogeneity in the pore size
distribution in mucus, which is visible in Fig. 3 D in (6).
Nevertheless, L as mean cavity size is the first-order
approximation, and the physical meaning should not be
overinterpreted in our oversimplified model, particularly
when our particles are assumed as nonextended tracers.
As we have already mentioned above, the presented
model does not consider chemical or electrostatic effects.
However, we are able to reproduce the experimental data
of either uncoated (charged) or coated (uncharged) particles,
according to Figs. 5 and 6.178 Biophysical Journal 112, 172–179, January 10, 2017Passage of nanoparticles through the mucus
layer
The presented model allows us to calculate the MSD(t)
outside the experimental accessible range of measurements
and gives an estimation of the mean time tp for particles to
penetrate the mucus layer of d ¼ 55 mm thickness. The
estimation is given by MSDðtpÞ  d2 and tpzd2=ð2DeffÞ.
Using the assumed Deff for particles from the previous sec-
tion, this calculation results in a mean passage time tp of
several hours. This passage time is significantly longer than
the time of 15 min required to renew the layer, given by the
mucociliary clearance (2,5,9). Even for a free Brownian mo-
tion ðMSDf2D0tÞ of 200 nm particles in a fluid with h ¼ 4
mPas, the passage time is approximately 1 h. It can be sum-
marized that particles with a diameter less than 40 nm are
able to pass through the mucus layer of d¼ 55 mm thickness
within a mucus turnover time of 15 min.CONCLUSIONS
We presented a model based on cellular structure with perme-
able membranes (22) to explain the experimental observed
transient subdiffusive behavior of nanoparticles in mucus.
Weapplied thismodel to reproduce theMSD-curves frompub-
lished particle-tracking experiments. Because of its confined
geometry, mucus is shown to be an excellent heterogeneous
material model to predict the transient subdiffusive regime
within the experimentally measurable time range. The model
includes two physically interpretable diffusion coefficients
D0ðh;RÞ for shorter times and DeffðpMÞ for longer times, as
well as the distance L between the membranes. The assumed
viscosity of the interstitial fluid is similar to that of water.
The permeability of the membranes is characterized by pM,
affecting Deff . We discussed a heuristic analytic approxima-
tion formula for the MSD(t) with the parameters D0, Deff ,
and L. The approximation was substantiated by detailed nu-
merical simulations based on permeable membranes in anal-
ogy to Robin boundary conditions. The model predicts a
normal diffusive behavior for short and long times. A subdif-
fusive regime appears only in between these times, if the
impermeability of the membranes is dominant. In agreement
with experimental data, we can conclude that particles with
a diameter less than 40nmare able to pass through the tracheo-
bronchial mucus layer (z55 mm) within a clearance time of
15min by passive Brownianmotion. To enable themucopene-
tration of particles, as reported for some viruses or some drug
delivery systems (1,9,10), other transport mechanisms and ef-
fects must be involved. To achieve a better insight in the sys-
tem, an analytic relation between the permeability pM in units
of s1=2 and the effective diffusion coefficientDeffðpMÞwill be
helpful (see Fig. 4). The model predicts normal diffusion for
short and long times and therefore, further experiments with
a wider range of time lag in the MSD(t)-data could verify
our predictions. Additionally, an experimental validation of
Transient Subdiffusive Behaviorthe Gaussian shape of the probability density function of the
particle displacement still remains elusive.SUPPORTING MATERIAL
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